Anthony P Morise1, Farrukh Jalisi. 1. Section of Cardiology, Department of Medicine, West Virginia University School of Medicine, Morgantown, WV 26506, USA. amorise@pol.net
Abstract
OBJECTIVES: To determine how well recently developed multivariables scores assess for all-cause mortality in patients with suspected coronary disease presenting for exercise electrocardiography (ExECG). BACKGROUND: Recently revised American College of Cardiology/American Heart Association guidelines for ExECG have suggested that ExECG scores be used to assist in management decisions in patients with suspected coronary artery disease. Recently developed scores accurately stratify patients according to angiographic disease severity. METHODS: To determine how well these scores assess for all-cause mortality, we utilized 4,640 patients without known coronary disease who underwent ExECG to evaluate symptoms of suspected coronary disease between 1995 and 2001. Previously validated pretest and exercise test scores as well as the Duke treadmill score were applied to each patient. All-cause mortality was our end point. RESULTS: Overall mortality was 3.0% with 2.8 +/- 1.6 years of follow-up. All three scores stratified patients into low-, intermediate-, and high-risk groups (p < 0.00001). No differences were seen when patients were evaluated as subgroups according to gender, diabetes, beta-blockers, or inpatient status. Low-risk patients defined by the Duke treadmill score had consistently higher mortality and absolute number of deaths compared with low-risk patients using other scores. In addition, the Duke treadmill score had less incremental stratifying value than the new exercise score. CONCLUSIONS: Simple pretest and exercise scores risk-stratified patients with suspected coronary disease in accordance with published guidelines and better than the Duke treadmill score. These results extend to diabetics, inpatients, women, and patients on beta-blockers.
OBJECTIVES: To determine how well recently developed multivariables scores assess for all-cause mortality in patients with suspected coronary disease presenting for exercise electrocardiography (ExECG). BACKGROUND: Recently revised American College of Cardiology/American Heart Association guidelines for ExECG have suggested that ExECG scores be used to assist in management decisions in patients with suspected coronary artery disease. Recently developed scores accurately stratify patients according to angiographic disease severity. METHODS: To determine how well these scores assess for all-cause mortality, we utilized 4,640 patients without known coronary disease who underwent ExECG to evaluate symptoms of suspected coronary disease between 1995 and 2001. Previously validated pretest and exercise test scores as well as the Duke treadmill score were applied to each patient. All-cause mortality was our end point. RESULTS: Overall mortality was 3.0% with 2.8 +/- 1.6 years of follow-up. All three scores stratified patients into low-, intermediate-, and high-risk groups (p < 0.00001). No differences were seen when patients were evaluated as subgroups according to gender, diabetes, beta-blockers, or inpatient status. Low-risk patients defined by the Duke treadmill score had consistently higher mortality and absolute number of deaths compared with low-risk patients using other scores. In addition, the Duke treadmill score had less incremental stratifying value than the new exercise score. CONCLUSIONS: Simple pretest and exercise scores risk-stratified patients with suspected coronary disease in accordance with published guidelines and better than the Duke treadmill score. These results extend to diabetics, inpatients, women, and patients on beta-blockers.
Authors: Jonathan Myers; Ricardo Oliveira; Frederick Dewey; Ross Arena; Marco Guazzi; Paul Chase; Daniel Bensimhon; Mary Ann Peberdy; Euan Ashley; Erin West; Lawrence P Cahalin; Daniel E Forman Journal: Circ Heart Fail Date: 2013-02-07 Impact factor: 8.790
Authors: Martin Hadamitzky; Tanja Meyer; Franziska Hein; Bernhard Bischoff; Robert A Byrne; Stefan Martinoff; Albert Schömig; Jörg Hausleiter Journal: Int J Cardiovasc Imaging Date: 2011-03-26 Impact factor: 2.357
Authors: Petar Medakovic; Zrinka Biloglav; Ivan Padjen; Ivan Pristas; Mladen Jukic; Franko Zuvela; Gordana Ivanac; Boris Brkljacic; Tena Jukic; Lana Turk Journal: Int J Cardiovasc Imaging Date: 2018-05-25 Impact factor: 2.357
Authors: Jamieson M Bourque; George T Charlton; Benjamin H Holland; Christopher M Belyea; Denny D Watson; George A Beller Journal: J Nucl Cardiol Date: 2010-12-04 Impact factor: 5.952
Authors: Pedro de Araújo Gonçalves; Hector M Garcia-Garcia; Helder Dores; Maria Salomé Carvalho; Pedro Jerónimo Sousa; Hugo Marques; Antonio Ferreira; Nuno Cardim; Rui Campante Teles; Luís Raposo; Henrique Mesquita Gabriel; Manuel Sousa Almeida; Ana Aleixo; Miguel Mota Carmo; Francisco Pereira Machado; Miguel Mendes Journal: Int J Cardiovasc Imaging Date: 2013-05-01 Impact factor: 2.357
Authors: Simon Deseive; Leslee J Shaw; James K Min; Stephan Achenbach; Daniele Andreini; Mouaz H Al-Mallah; Daniel S Berman; Matthew J Budoff; Tracy Q Callister; Filippo Cademartiri; Hyuk-Jae Chang; Kavitha Chinnaiyan; Benjamin J W Chow; Ricardo C Cury; Augustin DeLago; Allison M Dunning; Gudrun Feuchtner; Philipp A Kaufmann; Yong-Jin Kim; Jonathon Leipsic; Hugo Marques; Erica Maffei; Gianluca Pontone; Gilbert Raff; Ronin Rubinshtein; Todd C Villines; Jörg Hausleiter; Martin Hadamitzky Journal: Eur Heart J Cardiovasc Imaging Date: 2017-03-01 Impact factor: 6.875